掌閲科技(603533.SH):控股股東成湘均和張凌雲完成轉讓11.23%股份
格隆匯12月14日丨掌閲科技(603533.SH)公佈,公司控股股東、實際控制人成湘均和張凌雲分別將其持有的2252.25萬股無限售流通股份通過協議轉讓的方式轉讓給北京量子躍動科技有限公司(以下簡稱“量子躍動”)。本次協議轉讓已取得上海證券交易所合規性確認,並在中國證券登記結算有限責任公司上海分公司辦理完畢本次協議轉讓的過户手續。
本次協議轉讓完成後,量子躍動持有公司4504.50萬股股份,佔公司總股本的11.23%。本次協議轉讓不會導致公司實際控制權變更,公司控股股東、實際控制人仍為成湘均和張凌雲。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.